Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
pipeline
Biotech
AstraZeneca cuts early-phase prostate cancer pipeline
AstraZeneca has punted a pair of early-phase prostate cancer programs as part of its quarterly pipeline clear out.
Nick Paul Taylor
Oct 30, 2026 5:03am
Cadrenal launches strategic review for cardiology pipeline
Oct 7, 2026 12:54pm
Nuvig halts development of lead drug for rare autoimmune disease
Oct 6, 2026 2:48pm
Buzzy AI biotech Xaira unveils antibody platform ambitions
Oct 2, 2026 11:00am
Roche drops obesity antibody after flunked interim analysis
Sep 28, 2026 11:03am
Lilly cans early obesity drug after ‘high bar’ not met
Sep 14, 2026 12:45pm